TORNTPHARM

Torrent Pharma is currently one of the stronger pharma stocks in the Indian market due to: Strong domestic formulations business Consistent margin expansion Leadership in chronic therapies (cardiac, diabetes, gastro) Stable cash flows and improving profitability Recent quarterly numbers were healthy with: ✅ Revenue growth ✅ EBITDA margin improvement ✅ PAT growth around 11–15% YoY ✅ Strong India business traction Technical View Long-term trend remains bullish. Stock has been making higher highs and higher lows. Momentum is strong after recent earnings support. Pharma sector strength is also supporting the move. However: ⚠ Stock is trading at premium valuation compared to sector averages. ⚠ Sharp rallies can lead to short-term profit booking. Fundamental Positives ✅ Strong branded generics portfolio ✅ Good presence in India & Brazil markets ✅ Chronic therapy focus gives stable growth ✅ Low debt and healthy ROE/ROCE ✅ Possible long-term benefit from JB Chemicals integration synergies